Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Eberhard

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Micropublication Biology|April 8, 2021
cAMP export by the fission yeast <i>Schizosaccharomyces pombe</i>Jeremy Eberhard, Charles S Hoffman
Virology|October 1, 2013
Nuclear import of high risk HPV16 E7 oncoprotein is mediated by its zinc-binding domain via hydrophobic interactions with Nup62Jeremy Eberhard, Zeynep Onder, Junona Moroianu
The American Journal of Pathology|December 7, 2006
Role of endocytic inhibitory drugs on internalization of amyloidogenic light chains by cardiac fibroblastsGrace Fortes Monis, Christopher Schultz, Ruiyi Ren, et al.
Journal of Medicinal Chemistry|September 25, 2024
First Demonstration of <i>In Vivo</i> PDE11A4 Target Engagement for Potential Treatment of Age-Related Memory DisordersShams Ul Mahmood, Jeremy Eberhard, Charles S Hoffman, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Potent, Selective Pyrrolopyrimidine PDE11A4 Inhibitors with Improved Pharmaceutical PropertiesShams Ul Mahmood, Rama Krishna Boddu, Jeremy Eberhard, et al.
Journal of Medicinal Chemistry|October 20, 2023
First Optimization of Novel, Potent, Selective PDE11A4 Inhibitors for Age-Related Cognitive DeclineShams Ul Mahmood, Mariana Lozano Gonzalez, Sreedhar Tummalapalli, et al.
ACS Medicinal Chemistry Letters|April 15, 2026
Correction to "Potent, Selective Pyrrolopyrimidine PDE11A4 Inhibitors with Improved Pharmaceutical Properties"Shams Ul Mahmood, Rama Krishna Boddu, Jeremy Eberhard, et al.
Cellular Signalling|April 27, 2019
A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screeningRachel A Getz, Grace Kwak, Stacie Cornell, et al.
Cellular Signalling|March 28, 2026
A fission yeast-based platform for nematode PDE inhibitor discoverySarah Bibeau, Natalie Chen, Hannah Sutoris, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Micropublication Biology|April 8, 2021
cAMP export by the fission yeast <i>Schizosaccharomyces pombe</i>Jeremy Eberhard, Charles S Hoffman
Virology|October 1, 2013
Nuclear import of high risk HPV16 E7 oncoprotein is mediated by its zinc-binding domain via hydrophobic interactions with Nup62Jeremy Eberhard, Zeynep Onder, Junona Moroianu
The American Journal of Pathology|December 7, 2006
Role of endocytic inhibitory drugs on internalization of amyloidogenic light chains by cardiac fibroblastsGrace Fortes Monis, Christopher Schultz, Ruiyi Ren, et al.
Journal of Medicinal Chemistry|September 25, 2024
First Demonstration of <i>In Vivo</i> PDE11A4 Target Engagement for Potential Treatment of Age-Related Memory DisordersShams Ul Mahmood, Jeremy Eberhard, Charles S Hoffman, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Potent, Selective Pyrrolopyrimidine PDE11A4 Inhibitors with Improved Pharmaceutical PropertiesShams Ul Mahmood, Rama Krishna Boddu, Jeremy Eberhard, et al.
Journal of Medicinal Chemistry|October 20, 2023
First Optimization of Novel, Potent, Selective PDE11A4 Inhibitors for Age-Related Cognitive DeclineShams Ul Mahmood, Mariana Lozano Gonzalez, Sreedhar Tummalapalli, et al.
ACS Medicinal Chemistry Letters|April 15, 2026
Correction to "Potent, Selective Pyrrolopyrimidine PDE11A4 Inhibitors with Improved Pharmaceutical Properties"Shams Ul Mahmood, Rama Krishna Boddu, Jeremy Eberhard, et al.
Cellular Signalling|April 27, 2019
A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screeningRachel A Getz, Grace Kwak, Stacie Cornell, et al.
Cellular Signalling|March 28, 2026
A fission yeast-based platform for nematode PDE inhibitor discoverySarah Bibeau, Natalie Chen, Hannah Sutoris, et al.
Pageof 1